How do you approach gastric cancer with oligometastatic disease?

This is an area of ongoing evaluation and controversy. As with any such areas, there is a lot of dogma and no good data (other than single-center retrospective series from East Asia and, occasionally, the West). The FLOT5 study will indeed hopefully answer this question definitively.

FLOT5 is based o...